Rating History for Genmab (GMXAY) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/10/2018 | Graham Perry | Downgrade | Underperform (Buy) |
N/A (N/A) |
16.49 (18.35) |
11.28% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/10/2018 | Graham Perry | Downgrade | Underperform (Buy) |
N/A (N/A) |
16.49 (18.35) |
11.28% | Details |